No Data
Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts
Express News | Achilles: Proprietary data, TRACERx samples, and material acquisition platforms will be transferred to AstraZeneca.
Achilles Therapeutics Sells TRACERx And MAP Assets To AstraZeneca For $12M, Transferring Tumor Data And Samples; Concludes Strategic Review With Plans For Workforce And Board Reductions
Press Release: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca
London Shares Festive Ahead of Christmas Break; Vistry Slumps on Fresh Profit Warning
AstraZeneca, Daiichi Sankyo Withdraw EU Marketing Application for Lung Cancer Drug Candidate